Transverse myelitis unlikely to be due to measles, mumps, and rubella vaccine

BMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.7020.1642 (Published 16 December 1995) Cite this as: BMJ 1995;311:1642
  1. Reinhard Fescharek,
  2. Hermann Dass
  1. Head of pharmacovigilance Assistant director Behringwerke AG, Drug Surveillance Department, PO Box 11 40, 35001 Marburg, Germany

    EDITOR,--K A Joyce and J E Rees report on a 20 year old man who developed subacute transverse myelitis two to three weeks after immunisation with measles, mumps, and rubella vaccine.1 Five days after vaccination he developed a feverish exanthematous disease, which fluctuated for two weeks and preceded the onset of the neurological symptoms. Postvaccination transverse myelitis was diagnosed when a significant rise in titres of rubella antibodies was …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription